Introduction and Overview
Susan Hockfield, President, MIT; ; Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer Research and David H. Koch Professor, MITInvestigator, Howard Hughes Medical Institute;
Description: This inaugural address lays the groundwork for an 11-part series on MIT's efforts in cancer research. Susan Hockfield views MIT's Center for Cancer Research as a central example of how -life sciences are coming into conversation with engineering in a powerful way.” Robert Silbey provides historical background on the notion of faculty 'short courses', and positions the Center as -the jewel in the crown of MIT, a spawning ground for scientific discovery and rewards.” Tyler Jacks introduces the key research areas and scientists who will speak in the succeeding sessions. He offers a thumbnail sketch of cancer as a molecular genetic progression involving sequential alterations in, and the proliferation of, abnormal cells. -Think of a cancer cell like an integrated circuit: the same kinds of complexities in electronic networks also exist within cells,” notes Jacks. Because of work on the human genome, and advances in scientists' ability to untangle these complex molecular interactions, -We now have the first generation of anti-cancer drugs targeted against molecular alterations in cancer,” says Jacks. Two highly successful drugs have already been derived from MIT research. In addition, says Jacks, collaboration among biologists, engineers and mathematicians are yielding -a tremendous collection of tools and technologies.” These include tiny probes that enable diagnosis of cancers at earlier stages, nanoparticles that deliver a therapeutic payload directly to cancer cells, and devices that can be implanted in the body.
About the Speaker(s): Tyler Jacks received his A.B. in biology from Harvard College and his Ph.D. in Biochemistry and Biophysics from the University of California, San Francisco. His graduate work with Harold Varmus involved the mechanism of ribosomal frameshifting in retroviral gene expression. As a postdoctoral fellow with Robert Weinberg at the Whitehead Institute at MIT, Jacks initiated his studies on tumor-suppressor gene function, using gene targeting in the mouse. Jacks was named the 2005 Simon M. Shubitz Lecturer and Award recipient, and shared the 2005 Paul Marks Prize for Cancer Research awarded by Memorial Sloan-Kettering Cancer Center.
Host(s): School of Science, School of Science
It looks like no one has posted a comment yet. You can be the first!
More from MIT World — special events and lectures
Added almost 2 years ago | 01:28:00 | 1173 views
Added almost 2 years ago | 01:36:00 | 6839 views
Added almost 2 years ago | 01:16:00 | 1263 views
Added almost 2 years ago | 01:41:00 | 3295 views
Added almost 2 years ago | 01:09:00 | 4567 views
Added almost 2 years ago | 01:11:00 | 4529 views